VITAL THERAPIES INC Purchase Agreements
8 Contracts & Agreements
- Securities Purchase Agreement, dated January 4, 2024, by and among the Company and the Investors (Filed With SEC on January 5, 2024)
- Securities Purchase Agreement, dated October 10, 2022, by and among the Company and the Purchasers (Filed With SEC on October 11, 2022)
- Form of Securities Purchase Agreement, dated June 10, 2020, between the Company and the investors party thereto (Filed With SEC on June 12, 2020)
- Form of Securities Purchase Agreement, dated April 23, 2020, between the Company and the investors party thereto (Filed With SEC on April 27, 2020)
- Asset Purchase Agreement, dated May 13, 2016, between Immunic AG and 4SC AG (Filed With SEC on July 17, 2019)
- Second Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of April 4, 2019 (Filed With SEC on April 10, 2019)
- First Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of March 27, 2019 (Filed With SEC on April 10, 2019)
- Asset Purchase Agreement by and between RH Cell Therapeutics Corp and Vital Therapies, Inc., dated March 13, 2019 (Filed With SEC on March 19, 2019)
